Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.

Silvia Crescioli Giulia Chiaruttini Silvia Mele Kristina M Ilieva Giulia Pellizzari Daniel I R Spencer Richard A Gardner Katie E Lacy James F Spicer Andrew N J Tutt Gerd K Wagner Sophia N Karagiannis

J Allergy Clin Immunol

St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom; NIHR Biomedical Research Centre at Guy's and St Thomas's Hospitals and King's College London, London, United Kingdom; Breast Cancer Now Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom. Electronic address:

Published: April 2018

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286379	PMC
http://dx.doi.org/10.1016/j.jaci.2017.12.986	DOI Listing

Publication Analysis

Top Keywords

engineering stable

stable production

production recombinant

recombinant ige

ige cancer

cancer immunotherapy

immunotherapy allergooncology

engineering

production

recombinant

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!